Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
TRDA Quote, Financials, Valuation and Earnings
Last price:
$10.43
Seasonality move
:
-39.89%
Day range:
$10.40 - $10.79
52-week range:
$4.93 - $18.76
Dividend yield:
0%
P/E ratio:
7.16x
P/S ratio:
7.18x
P/B ratio:
1.19x
Volume:
71.1K
Avg. volume:
240.7K
1-year change:
-39.75%
Market cap:
$404.4M
Revenue:
$210.8M
EPS (TTM):
-$2.50
Earnings Data
Next earnings date for TRDA
Feb 26
2026
Most recent earnings per share
-$1.06
Missed by $0.10
(Nov 6/2025)
Consensus Estimate
-$0.97
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TRDA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $8.5M | -- | -- | -$0.95 | -- |
| 11/06/2025 | Q3 | $8.6M | $1.6M | -$1.06 | -$0.97 | -$0.10 |
| 08/13/2025 | Q2 | $8.2M | $2M | -$1.04 | -$0.86 | -$0.18 |
| 05/06/2025 | Q1 | $10.2M | $20.6M | -$0.42 | -$0.78 | $0.35 |
| 02/27/2025 | Q4 | $12.9M | $37.4M | $0.03 | -$0.66 | $0.69 |
| 11/05/2024 | Q3 | $11.9M | $19.6M | -$0.35 | -$0.63 | $0.28 |
| 08/13/2024 | Q2 | $36.4M | $94.7M | $1.55 | $0.33 | $1.22 |
| 05/07/2024 | Q1 | $15.2M | $59.1M | $0.68 | -$0.47 | $1.14 |
| 03/13/2024 | Q4 | $23.7M | $41.8M | -$0.29 | -$0.14 | -$0.15 |
| 11/07/2023 | Q3 | -- | $43.7M | $1.02 | -- | -- |
| 08/08/2023 | Q2 | -- | $18.2M | -$0.78 | -- | -- |
| 05/10/2023 | Q1 | -- | $25.3M | -$0.21 | -- | -- |
| 03/06/2023 | Q4 | -- | -- | -$0.79 | -- | -- |
| 11/07/2022 | Q3 | -- | -- | -$0.80 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.74 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.69 | -- | -- |
| 03/15/2022 | Q4 | -- | -- | -$0.59 | -- | -- |
| 12/09/2021 | Q3 | -- | -- | -$0.46 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.48 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.27 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.42 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.22 | -- | -- |
Entrada Therapeutics, Inc. Earnings Questions
-
How Much did Entrada Therapeutics, Inc. Generate in Revenue Last Quarter?
Entrada Therapeutics, Inc. reported $1.6M worth of top line sales in its most recent quarter.
-
Did Entrada Therapeutics, Inc. Beat Earnings Last Quarter?
Entrada Therapeutics, Inc. announced earnings per share of -$1.06 which represents a miss of analyst forecast a -$0.97 per share.
-
Is Entrada Therapeutics, Inc. Profitable?
Entrada Therapeutics, Inc. reported $414K that represents $0.01 per share over the last quarter.
-
What is the Analyst Consensus for Entrada Therapeutics, Inc. EPS Next Year?
Entrada Therapeutics, Inc.'s earnings are forecast to decrease from $1.68 per share to $1.07 per share next year representing a decrease of -100%.
-
When is Entrada Therapeutics, Inc.'s Earnings Date?
Entrada Therapeutics, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 3.73% over the past day.
Buy
60
AAOI alert for Dec 26
Applied Optoelectronics, Inc. [AAOI] is down 9.39% over the past day.
